查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595330

苯酮尿症治疗市场：按给药途径、产品和分销划分 - 2025-2030 年全球预测

Phenylketonuria Treatment Market by Route of Administration (Oral, Parenteral), Product (Dietary Supplement, Drugs), Distribution - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年苯酮尿症治疗市值为74234万美元，预计2024年将达到84056万美元，复合年增长率为13.32%，到2030年将达到178182万美元。

苯酮尿症 (PKU) 的治疗涉及一种罕见的遗传性疾病，其特征是氨基酸苯丙胺酸代谢失败，如果不治疗，可能会导致严重的认知障碍。 PKU 治疗市场的范围涵盖早期诊断和终身饮食管理等必需品，并辅以酵素替代疗法和基因疗法等药物干预措施。应用围绕着防止苯丙胺酸积聚的膳食产品和医疗食品，而新的药物解决方案提供了变革性的方法。最终用途将主要集中在出生时诊断的婴幼儿和儿童以及饮食受限的成年人，其中专科诊所和医院是关键接触点。市场成长是由意识的提高、新生儿筛检的增加以及治疗技术的进步所推动的。新型疗法的开发，包括 pegvariase 和基因疗法的潜力，代表了潜在的成长机会，并支持药物开发方面的策略伙伴关係，以扩大产品系列。然而，挑战仍然存在，主要是与治疗相关的高昂费用、资源匮乏地区的获取机会有限以及影响患者生活品质的终生坚持饮食方案的复杂性。儘管有这些限制，生物工程酶和基因编辑等替代治疗剂的动态性质正在为技术创新铺平道路。创新的热门领域包括开发更实惠、更容易取得的饮食管理产品、扩大现有药物的适应症，以及透过先进的生物技术提高治疗效果。进行全面的现实世界临床试验以了解纵向治疗结果将极大地帮助相关人员应对这一复杂的情况。为了抓住快速成长的机会，加强与学术机构和生技公司的策略联盟可以加速将前沿研究转化为可行的治疗方法。最终，PKU 治疗市场的特点是竞争和协作的环境，旨在提供具有成本效益和以患者为中心的解决方案，以普遍提高生活品质。

主要市场统计
基准年[2023] 74234万美元
预测年份 [2024] 84056万美元
预测年份 [2030] 1,781.82 百万美元
复合年增长率（%） 13.32%

市场动态：快速发展的苯酮尿症治疗市场的关键市场洞察

供需的动态交互作用正在改变苯酮尿症治疗市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 苯酮尿症 (PKU) 疾病的发生率增加
    • 苯酮尿症治疗期间和治疗后的相关益处
    • 不断进行提高人们对苯酮尿症认识的倡议
  • 市场限制因素
    • 不利的报销政策
  • 市场机会
    • 基于管道药物库存的未来性
    • 基因组学和生物技术领域研究的成长
  • 市场挑战
    • 与 PKU 治疗相关的整体高成本

波特五力：驾驭苯酮尿症治疗市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解苯酮尿症治疗市场的外部影响

外部宏观环境因素在塑造苯酮尿症治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解苯酮尿症治疗市场的竞争状况

对苯酮尿症治疗市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵苯酮尿症治疗市场供应商的绩效评估

FPNV 定位矩阵是评估苯酮尿症治疗市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製苯酮尿症治疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对苯酮尿症治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 苯酮尿症 (PKU) 疾病的发生率增加
      • 苯酮尿症治疗期间和治疗后的益处
      • 加大力度提高人们对 PKU 症状的认识
    • 抑制因素
      • 不利的退款政策
    • 机会
      • 管道药物库存的未来性
      • 基因组学和生物技术领域的研究进展
    • 任务
      • PKU 治疗相关的总体成本较高
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章苯酮尿症治疗市场：依给药途径

  • 口服
  • 胃肠外的

第七章苯酮尿症治疗市场：副产品

  • 食品补充品
  • 药品
    • 生物膜
    • 库万

第八章苯酮尿症治疗市场经销商

  • 药局
  • 医院药房
  • 网路药房
  • 小儿科诊所

第九章 北美和南美苯酮尿症治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区苯酮尿症治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲苯酮尿症治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
  • 战略分析和建议

公司名单

  • Ajinomoto Cambrooke, Inc.
  • American Gene Technologies International Inc.
  • BioMarin Pharmaceutical Inc.
  • BioMarin Pharmaceuticals, Inc.
  • Codexis, Inc.
  • Daiichi Sankyo Company, Limited
  • ERYTECH Pharma SA
  • Homology Medicines, Inc.
  • Nutricia by Danone
  • PTC Therapeutics
  • Reckitt Benckiser Group PLC
  • Rubius Therapeutics, Inc.
  • Synlogic, Inc.
  • Ultragenyx Pharmaceutical
  • Ultragenyx Pharmaceutical Inc.
Product Code: MRR-030EE485160A

The Phenylketonuria Treatment Market was valued at USD 742.34 million in 2023, expected to reach USD 840.56 million in 2024, and is projected to grow at a CAGR of 13.32%, to USD 1,781.82 million by 2030.

Phenylketonuria (PKU) treatment pertains to addressing a rare genetic disorder characterized by the inability to metabolize phenylalanine, an amino acid, potentially leading to severe cognitive impairment if untreated. The scope of the PKU treatment market spans necessities such as early diagnosis and lifelong dietary management, complemented by pharmaceutical interventions like enzyme replacement therapies and gene therapy prospects. The application largely revolves around dietary products and medical foods preventing phenylalanine accumulation, while emerging pharmaceutical solutions offer a transformative approach. End-use primarily focuses on infants diagnosed at birth, children, and adults under dietary restrictions, with specialist clinics and hospitals as critical touchpoints. Market growth is fueled by rising awareness, increased newborn screening, and technological advancements in treatment methodologies. The development of novel therapeutics, including pegvaliase and potential gene therapies, signifies potential growth opportunities, encouraging strategic partnerships in drug development for expanded product portfolios. However, challenges persist, primarily due to high costs associated with treatment and limited access in resource-constrained regions, coupled with cumbersome lifelong dietary adherence impacting patient quality of life. Despite these limitations, the dynamic nature of surrogate therapeutics, such as bioengineered enzymes and gene editing, paves the way for innovation. The top innovation areas include developing more affordable and accessible dietary management products, expanding indications for existing pharmaceuticals, and enhancing therapeutic efficacy through advanced biotechnology. Conducting comprehensive, real-world studies to capture longitudinal treatment outcomes can greatly aid stakeholders in navigating this complex landscape. To capture burgeoning opportunities, bolstering strategic alliances with academic institutions and biotech companies can spur the translation of cutting-edge research into viable treatments. Ultimately, the PKU treatment market is characterized by a competitive yet collaborative environment, aiming for cost-effective, patient-centric solutions to improve life quality universally.

KEY MARKET STATISTICS
Base Year [2023] USD 742.34 million
Estimated Year [2024] USD 840.56 million
Forecast Year [2030] USD 1,781.82 million
CAGR (%) 13.32%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Phenylketonuria Treatment Market

The Phenylketonuria Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of phenylketonuria (PKU) disorders
    • Benefits associated with ongoing and after the phenylketonuria treatment
    • Rising initiatives for the awareness of the PKU condition
  • Market Restraints
    • Unfavorable reimbursement policies
  • Market Opportunities
    • Future potential due to stock of pipeline drugs
    • Growing research in the field of genomics and biotechnology
  • Market Challenges
    • Overall high cost associated with PKU treatment

Porter's Five Forces: A Strategic Tool for Navigating the Phenylketonuria Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Phenylketonuria Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Phenylketonuria Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Phenylketonuria Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Phenylketonuria Treatment Market

A detailed market share analysis in the Phenylketonuria Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Phenylketonuria Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Phenylketonuria Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Phenylketonuria Treatment Market

A strategic analysis of the Phenylketonuria Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Phenylketonuria Treatment Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Cambrooke, Inc., American Gene Technologies International Inc., BioMarin Pharmaceutical Inc., BioMarin Pharmaceuticals, Inc., Codexis, Inc., Daiichi Sankyo Company, Limited, ERYTECH Pharma S.A., Homology Medicines, Inc., Nutricia by Danone, PTC Therapeutics, Reckitt Benckiser Group PLC, Rubius Therapeutics, Inc., Synlogic, Inc., Ultragenyx Pharmaceutical, and Ultragenyx Pharmaceutical Inc..

Market Segmentation & Coverage

This research report categorizes the Phenylketonuria Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Route of Administration, market is studied across Oral and Parenteral.
  • Based on Product, market is studied across Dietary Supplement and Drugs. The Drugs is further studied across Biopten and Kuvan.
  • Based on Distribution, market is studied across Drug Stores, Hospital Pharmacies, Online Pharmacies, and Pediatric Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of phenylketonuria (PKU) disorders
      • 5.1.1.2. Benefits associated with ongoing and after the phenylketonuria treatment
      • 5.1.1.3. Rising initiatives for the awareness of the PKU condition
    • 5.1.2. Restraints
      • 5.1.2.1. Unfavorable reimbursement policies
    • 5.1.3. Opportunities
      • 5.1.3.1. Future potential due to stock of pipeline drugs
      • 5.1.3.2. Growing research in the field of genomics and biotechnology
    • 5.1.4. Challenges
      • 5.1.4.1. Overall high cost associated with PKU treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Phenylketonuria Treatment Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Oral
  • 6.3. Parenteral

7. Phenylketonuria Treatment Market, by Product

  • 7.1. Introduction
  • 7.2. Dietary Supplement
  • 7.3. Drugs
    • 7.3.1. Biopten
    • 7.3.2. Kuvan

8. Phenylketonuria Treatment Market, by Distribution

  • 8.1. Introduction
  • 8.2. Drug Stores
  • 8.3. Hospital Pharmacies
  • 8.4. Online Pharmacies
  • 8.5. Pediatric Clinics

9. Americas Phenylketonuria Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Phenylketonuria Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Phenylketonuria Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ajinomoto Cambrooke, Inc.
  • 2. American Gene Technologies International Inc.
  • 3. BioMarin Pharmaceutical Inc.
  • 4. BioMarin Pharmaceuticals, Inc.
  • 5. Codexis, Inc.
  • 6. Daiichi Sankyo Company, Limited
  • 7. ERYTECH Pharma S.A.
  • 8. Homology Medicines, Inc.
  • 9. Nutricia by Danone
  • 10. PTC Therapeutics
  • 11. Reckitt Benckiser Group PLC
  • 12. Rubius Therapeutics, Inc.
  • 13. Synlogic, Inc.
  • 14. Ultragenyx Pharmaceutical
  • 15. Ultragenyx Pharmaceutical Inc.

LIST OF FIGURES

  • FIGURE 1. PHENYLKETONURIA TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. PHENYLKETONURIA TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PHENYLKETONURIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PHENYLKETONURIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHENYLKETONURIA TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHENYLKETONURIA TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY BIOPTEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY KUVAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PEDIATRIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM PHENYLKETONURIA TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM PHENYLKETONURIA TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 189. PHENYLKETONURIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 190. PHENYLKETONURIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023